Soe Myat Maw, MD
Pediatrics · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Maw’s office at (408) 457-7100 to ask if they take your plan before you enroll.
California Medical Board record
Licence A138059 · Current
Licensed to practise in California · since 2015 · expires 2028-12-31 · University of Miami School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$175,978 in 2024
Medicaid paid $175,978 for 2,260 billed services this clinician did in 2024, up to 83 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 624 | $173,562 |
| Short return visit (20+ min) | 247 | $1,969 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 21 | $289 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; late childhood (age 5 through 11 years) | 57 | $100 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 317 | $45 |
| HEMOGLOBIN | 262 | $14 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 191 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 107 | $0 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 13 | $0 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 31 | $0 |
| Pneumococcal conjugate vaccine, 15 valent (PCV15), for intramuscular use | 17 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 16 | $0 |
| 2024 | 2,260 | 15 | 83 | $175,978 |
| 2023 | 397 | 7 | 33 | $35,325 |
| 2022 | 1,376 | 18 | 214 | $104,658 |
| 2021 | 6,534 | 20 | 265 | $633,932 |
| 2020 | 3,721 | 16 | 203 | $285,376 |
| 2019 | 5,695 | 20 | 259 | $630,320 |
| 2018 | 3,631 | 26 | 243 | $284,868 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 123 | $34,957 |
| Short return visit (20+ min) | 132 | $369 |
| HEMOGLOBIN | 33 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; first or only component of each vaccine or toxoid administered | 42 | $0 |
| Immunization administration through 18 years of age via any route of administration, with counseling by physician or other qualified health care professional; each additional vaccine or toxoid component administered (List separately in addition to code for primary procedure) | 15 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 13 | $0 |
| Screening performed and negative | 39 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 335 | $103,131 |
| Service | 14 | $602 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 30 | $461 |
| Short return visit (20+ min) | 484 | $164 |
| Subsequent hospital care, per day, for evaluation and management of normal newborn | 17 | $136 |
| Initial hospital or birthing center care, per day, for evaluation and management of normal newborn infant | 12 | $97 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 37 | $66 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 13 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 32 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 61 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 24 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 69 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 2,072 | $632,107 |
| Service | 31 | $1,334 |
| Short return visit (20+ min) | 1,905 | $442 |
| Initial comprehensive preventive medicine evaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, new patient; infant (age younger than 1 year) | 60 | $45 |
| Measurement of bilirubin | 40 | $4 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 27 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 320 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 73 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 40 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 144 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 236 | $0 |
| Hepatitis B vaccine (HepB), pediatric/adolescent dosage, 3 dose schedule, for intramuscular use | 78 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 1,025 | $285,299 |
| Short return visit (20+ min) | 815 | $55 |
| Short return visit | 90 | $22 |
| Measurement of bilirubin | 17 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 77 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 182 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 14 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 424 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 172 | $0 |
| Hepatitis B vaccine (HepB), pediatric/adolescent dosage, 3 dose schedule, for intramuscular use | 95 | $0 |
| Screening test, pure tone, air only | 150 | $0 |
| Bilateral quantitative screening test of visual acuity | 152 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 2,665 | $629,460 |
| Service | 20 | $861 |
| Measurement of bilirubin | 24 | $0 |
| Hepatitis A vaccine (HepA), pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 67 | $0 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 49 | $0 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 199 | $0 |
| Rotavirus vaccine, pentavalent (RV5), 3 dose schedule, live, for oral use | 41 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 384 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, Haemophilus influenzae type b, and inactivated poliovirus vaccine, (DTaP-IPV/Hib), for intramuscular use | 116 | $0 |
| DIPHTH TETANUS TOX ACELL PERTUSSIS VACC<7 YR IM | 12 | $0 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 14 | $0 |
| Hepatitis B vaccine (HepB), pediatric/adolescent dosage, 3 dose schedule, for intramuscular use | 57 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 1,196 | $261,388 |
| Short return visit (20+ min) | 892 | $5,672 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 111 | $4,389 |
| Service | 114 | $3,887 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 82 | $3,313 |
| Return visit (30+ min) | 127 | $1,537 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 146 | $1,453 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 99 | $863 |
| Service | 20 | $861 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 154 | $382 |
| Haemophilus influenzae type b vaccine, PRP-OMP conjugate | 97 | $319 |
| Diphtheria, tetanus toxoids, acellular pertussis vaccine, hepatitis B, and inactivated poliovirus vaccine (DTaP-HepB-IPV), for intramuscular use | 79 | $262 |
Money from drug and device companies
$78 in 2024
A payment is not proof that care is biased.
| Sanofi Pasteur | Beyfortus | $52 | 2 payments
|
| GlaxoSmithKline | Arexvy | $25 | 1 payment
|
See all 3 published payments
| Sanofi Pasteur | Meals · 2024-11-08 | Beyfortus | $30 |
| Sanofi Pasteur | Meals · 2024-01-29 | Beyfortus | $22 |
| GlaxoSmithKline | Meals · 2024-01-25 | Arexvy | $25 |
Professional record
- NPI
- 1285053090
- Licence
- CA A138059California A138059: Current · expires 2028-12-31
More record details
- Sole proprietor
- No
- Taxonomy
- Pediatrics (208000000X)
- Mailing address
- 195 E Virginia St, San Jose, CA, 95112
- NPI first listed
- 2014-04-08
- NPI last updated
- 2026-02-04
- NPI record certified
- 2026-02-04
This is when the NPI record was last certified, not a medical board exam.